Century Therapeutics Inc (IPSC)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $297.82M
Last updated: Nov 17, 2026 at 4:26 PM ET
Century Therapeutics Inc (IPSC) Stock Chart
Century Therapeutics (IPSC) has a latest price of $1.37 on Nov 17, 2026, 54.9% below its 52-week high of $3.04. Its price rose 190.1% over the past 12 months. The month-end price fell 93.5% over the 5 years through Oct 2026, a compound annual decline of 42.0%.
Price Chart
From Jun 2021 to Oct 2026, its highest month-end close was $29.34 in Jun 2021 and its lowest $0.48 in Mar 2025, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart IPSC with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for IPSC.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 35.1%, and over 6 months it fell 35.4%. The month-end price fell 3.9% over the 3 years through Oct 2026, a compound annual decline of 1.3%.
| Period | Change |
|---|---|
| 1 month | -6.8% |
| 3 months | -35.1% |
| 6 months | -35.4% |
| 12 months | +190.1% |
| 12 months, with dividends | +190.1% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -3.9% | -1.3% |
| 5 years | -93.5% | -42.0% |
Price by Year
Its best calendar year was 2025, when the price fell 1.5%, and its weakest was 2024, when it fell 69.6%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $1.47 | +47.8% |
| 2025 | $0.99 | -1.5% |
| 2024 | $1.01 | -69.6% |
| 2023 | $3.32 | -35.3% |
| 2022 | $5.13 | -67.7% |
Trading Range
The price is 15.5% below its 50-day average of $1.62 and 33.5% below its 200-day average of $2.06.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $1.37 | |
| 52-week high | $3.04 | -54.9% |
| 52-week low | $0.46 | +195.3% |
| 50-day average | $1.62 | -15.5% |
| 200-day average | $2.06 | -33.5% |
Price Risk
Over 3 years, its largest fall from a peak was 92.7%.
| Measure | Value |
|---|---|
| 1-year beta | 2.19 |
| Largest fall, 1 year | -56.5% |
| Largest fall, 3 years | -92.7% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About IPSC
What is IPSC's 1-year price change?
Century Therapeutics's price rose 190.1% over the past 12 months. With dividends included, the 12-month total return was 190.1%.
What is IPSC's 5-year price change?
Century Therapeutics's month-end price fell 93.5% over the 5 years through Oct 2026, a compound annual decline of 42.0%. These figures leave out dividends.
What is IPSC's 52-week high and low?
Century Therapeutics's 52-week high is $3.04 and its 52-week low is $0.46. Its latest price of $1.37 on Nov 17, 2026 is 54.9% below the high.
What is IPSC's beta?
Century Therapeutics's 1-year beta against the S&P 500 is 2.19, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 56.5%.
Is the IPSC chart free?
Yes. Advanced Charting for IPSC is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
IPSC pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors